What is the ticker symbol for Orchestra BioMed?

Orchestra BioMed trades under the ticker OBIO on NASDAQ.

What sector does Orchestra BioMed operate in?

Orchestra BioMed is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OBIO in a portfolio?

PortView shows OBIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Orchestra BioMed (OBIO) Stock Analysis

NASDAQHealthcareBiotechnology

$4.89-0.20%

1-year price historyRange $2.35 – $5.66

52-week range$4.89

$2.20$5.78

What Orchestra BioMed does

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.

Key metrics

Market cap

$292.82M

P/E (TTM)

-5.04

EPS (TTM)

$-0.97

Beta

0.50

Dividend yield

0.00%

Revenue / share

$0.50

50-day avg

$4.32

200-day avg

$4.26

52-week high

$5.78

52-week low

$2.20

CEO

David Hochman

ETFs linked to OBIO

Broad-market and Healthcare sector ETFs an investor holding Orchestra BioMed is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OBIO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OBIO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Orchestra BioMed?: Orchestra BioMed trades under the ticker OBIO on NASDAQ.
Which exchange is OBIO listed on?: OBIO is listed on NASDAQ.
What sector does Orchestra BioMed operate in?: Orchestra BioMed is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OBIO in a portfolio?: PortView shows OBIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.